Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 146
Immune Disorders Drugs 129
Central Nervous System Drugs 127
Biopharmaceuticals 88
Pharmaceuticals 86
Hematological Drugs 78
Vaccines 78
Clinical Trials 72
Drug Discovery 67
Cardiovascular Drugs 58
Infectious Diseases Drugs 58
Diabetes Drugs 56
Leukemia Drugs 52
Mental Disorders Drugs 45
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 40
Infusions and Injectables 33
Liver and Kidney Disorders Drugs 32
Over the Counter (OTC) Drugs 31
Lung Cancer Drugs 22
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 19
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Prostate Cancer Drugs 12
Skin Cancer Drugs 12
Schizophrenia Drugs 12
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,647 Results (Page 73 of 83)
- Relevance
  Sort by

Europe Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
107 Pages
Europe

From

€1326EUR$1,500USD£1,168GBP

Asia Pacific Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
107 Pages
Asia Pacific

From

€1326EUR$1,500USD£1,168GBP

Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025

 Clinical Trials
May 2025
5100 Pages
Global

From

€3049EUR$3,450USD£2,686GBP

Endometriosis - Global Clinical Trials Review, 2025

 Clinical Trials
May 2025
529 Pages
Global

From

€3049EUR$3,450USD£2,686GBP

Regenerative Medicine Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
179 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Insomnia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
163 Pages
Global

€4414EUR$4,995USD£3,889GBP

Biological Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
90 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

Anti-Hypertension Drugs Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
November 2024
108 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

Pancreatic Cancer - Pipeline Review, H2 2020

 Drug Pipelines
September 2020
4317 Pages
Global

From

€2209EUR$2,500USD£1,946GBP

Gonorrhea Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€4373EUR$4,949USD£3,853GBP

Lennox Gastaut Syndrome - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1060EUR$1,200USD£934GBP

€1326EUR$1,500USD£1,168GBP

Dravet Syndrome- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1060EUR$1,200USD£934GBP

€1326EUR$1,500USD£1,168GBP

Ulcerative Colitis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
115 Pages
Global

From

€4198EUR$4,750USD£3,698GBP

Depression Treatment Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
July 2023
133 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

Integrin Alpha 4 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
January 2024
91 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

High Potency APIs Global Market Opportunities And Strategies To 2031

 Report
July 2022
230 Pages
Global

From

€4418EUR$5,000USD£3,893GBP

Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€884EUR$1,000USD£779GBP

€1105EUR$1,250USD£973GBP

Dyslipidemia Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,243USD£3,191GBP

Spinal Muscular Atrophy Treatment Market Report and Forecast 2025-2034

 Report
June 2025
400 Pages
Global

From

€4373EUR$4,949USD£3,853GBP

Dopamine D2 Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1060EUR$1,200USD£934GBP

€1326EUR$1,500USD£1,168GBP

1,647 Results (Page 73 of 83)
- 1
- 71
- 72
- 73
- 74
- 75

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.